ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001

President Drops Revision Plan; NCI To Receive $937.1 Million Voted By Congress For FY 1979

January 12, 1979

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002